Kodiak Sciences Inc. - ROE
KOD
Price:
$36.14
Market Cap:
$1.91B
Kodiak Sciences Inc. is a biopharmaceutical firm currently in the clinical development phase, dedicated to discovering, advancing, and bringing to market treatments for various conditions affecting the retina. Their primary drug candidate, KSI-301, is an anti-vascular endothelial growth factor (anti-VEGF) antibody biopolymer. This compound is currently undergoing Phase IIb/III clinical trials, targeting illnesses such as wet age-related macular degeneration (AMD), diabetic macular edema, previously untreated macular edema resulting from retinal vein occlusion, and non-proliferative diabetic retinopathy. In its earlier, preclinical development pipeline, the company is also working on KSI-501,...[Read more]
Industry
Biotechnology
IPO Date
2018-10-04
Stock Exchange
NASDAQ
Ticker
KOD
PE Ratio
[-8.65]
ROE
[-253.85%]
Current Ratio
[3.54]
Dividend Yield
[0%]
Enterprise Value
[1.90B]
Dividend History
The ROE as of June 2026 (TTM) for Kodiak Sciences Inc. (KOD) is -253.85%
According to Kodiak Sciences Inc.’s latest financial reports and current stock price. The company's current ROE is -253.85%. This represents a change of 139.14% compared to the average of -106.15% of the last 4 quarters.
Kodiak Sciences Inc. (KOD) Historical ROE (quarterly & annually)
How has KOD ROE performed in the past?
The mean historical ROE of Kodiak Sciences Inc. over the last ten years is -47.27%. The current -253.85% ROE has changed 436.99% with respect to the historical average. Over the past ten years (40 quarters), KOD's ROE was at its highest in in the March 2018 quarter at 54.32%. The ROE was at its lowest in in the September 2025 quarter at -259.40%.
Average
-47.27%
Median
-43.99%
Minimum
-146.12%
Maximum
41.70%
Kodiak Sciences Inc. (KOD) ROE by Quarter and Year
Discovering the peaks and valleys of Kodiak Sciences Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 160.31%
Maximum Annual ROE = 41.70%
Minimum Annual Increase = -217.44%
Minimum Annual ROE = -146.12%
| Year | ROE | Change |
|---|---|---|
| 2025 | -146.12% | 24.63% |
| 2024 | -117.25% | 19.63% |
| 2023 | -98.01% | 28.06% |
| 2022 | -76.54% | 90.15% |
| 2021 | -40.25% | 160.31% |
| 2020 | -15.46% | 12.75% |
| 2019 | -13.71% | -71.26% |
| 2018 | -47.73% | -217.44% |
| 2017 | 40.64% | -2.54% |
Kodiak Sciences Inc. (KOD) Average ROE
How has KOD ROE performed in the past?
The current ROE of Kodiak Sciences Inc. (KOD) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-120.46%
5-year avg
-95.63%
10-year avg
-47.27%
Kodiak Sciences Inc. (KOD) ROE vs. Peers
How is KOD’s ROE compared to its peers?
Kodiak Sciences Inc.’s ROE is greater than Nurix Therapeutics, Inc. (-64.21%), greater than Xencor, Inc. (-28.77%), less than Phathom Pharmaceuticals, Inc. (39.24%), greater than Oculis Holding AG (-57.09%), greater than EyePoint Pharmaceuticals, Inc. (-110.54%), less than UroGen Pharma Ltd. (121.52%), less than AnaptysBio, Inc. (442.91%), greater than BridgeBio Oncology Therapeutics Inc. (-61.49%), greater than Tango Therapeutics, Inc. (-41.54%), less than ProKidney Corp. (7.40%),
| Company | ROE | Market cap |
|---|---|---|
| -64.21% | $1.52B | |
| -28.77% | $937.15M | |
| 39.24% | $867.74M | |
| -57.09% | $641.44M | |
| -110.54% | $1.14B | |
| 121.52% | $1.64B | |
| 442.91% | $2.48B | |
| -61.49% | $605.61M | |
| -41.54% | $3.48B | |
| 7.40% | $615.34M |
Build a custom stock screener for Kodiak Sciences Inc. (KOD) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Kodiak Sciences Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Kodiak Sciences Inc. (KOD) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Kodiak Sciences Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Kodiak Sciences Inc.'s ROE?
How is the ROE calculated for Kodiak Sciences Inc. (KOD)?
What is the highest ROE for Kodiak Sciences Inc. (KOD)?
What is the 3-year average ROE for Kodiak Sciences Inc. (KOD)?
What is the 5-year average ROE for Kodiak Sciences Inc. (KOD)?
How does the current ROE for Kodiak Sciences Inc. (KOD) compare to its historical average?